Abu Dhabi Announces Multifaceted Enhancements to Increase the 35%++ Cashback Rebate
With a sliding-scale points system and clear qualifying criteria, productions have the opportunity to gain up to 50% total cashback rebate Guidelines have also been enhanced; supporting additional production formats, increased total financial...
Huawei and Moroccan Government Boost National Education Transformation through DigiSchool Project
AGADIR, Morocco, Dec. 30, 2024 /PRNewswire/ -- Huawei has announced the successful completion of the DigiSchool 2024 project in Morocco, highlighting its contribution to ensuring equitable access to digital technology for all students in the...
Dahua Technology Obtains ISO 37301 Compliance Management System Certification
HANGZHOU, China, Dec. 30, 2024 /PRNewswire/ -- Dahua Technology, a world-leading video-centric AIoT solution and service provider, has officially obtained the ISO 37301:2021 Compliance Management System Certification from British Standards...
Vivien Lin Celebrates a Year of Transformative Leadership as BingX's CPO
VILNIUS, Lithuania, Dec. 30, 2024 /PRNewswire/ -- BingX, a leading global cryptocurrency exchange, proudly celebrates the one-year anniversary of Vivien Lin's tenure as Chief Product Officer (CPO). Lin's leadership has been instrumental in...
Pimax launches the world's smallest full-feature 8K resolution headset: the Pimax Dream Air
TOKYO, Dec. 30, 2024 /PRNewswire/ -- Pimax, a manufacturer of leading VR hardware, released in an online keynote presentation the design and specs of an upcoming headset, the Pimax Dream Air. The small and light headset packs 27 million pixels,...
Alphamab Oncology Announced Anti-HER2 Bispecific ADC JSKN003 Received Approval from CDE to Initiate a Phase III Clinical Study for Ovarian Cancer
SUZHOU, China, Dec. 27, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 has received approval from the Center for Drug Evaluation (CDE) of the National Medical...
Maypharm Unveils Revolutionary Hybrid Filler, Hyalmass Aqua-Exosome: The Future of Skin Hydration and Regeneration
Introducing Hyaluronic Acid, Exosomes, and PDRN SEOUL, South Korea, Dec. 30, 2024 /PRNewswire/ -- Maypharm Co., Ltd., a leading innovator in medical and dermo-cosmetic products, proudly introduces the global launch of Hyalmass Aqua-Exosome, a...
Huadong Medicine Co., Ltd. and SynerK reached a strategic cooperation to jointly develop a novel siRNA drug SNK-2726
SUZHOU, China, Dec. 30, 2024 /PRNewswire/ -- Hangzhou Sino-US Huadong Medicine Co., Ltd. (hereinafter referred to as "Huadong Medicine"), a wholly-owned subsidiary of Huadong Medicine Co., Ltd. (SZ.000963), and SynerK PharmaTech (Suzhou) Co., Ltd....